Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:16 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3CompletedINTERVENTIONAL

A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation

ClinicalTrials.gov · NCT02449889 · Registry updated: 2019-06-26

Condition / research focus: Infertility
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: Brazil
Registry dates and results: Start: 2016-04. Completion: 2018-03-01 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

highly purified human chorionic gonadotropin (drug) — also listed as: CHORAPUR, BREVACTID
recombinant human chorionic gonadotropin (drug) — also listed as: OVIDREL, OVITRELLE

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Instituto Ideia Fértil de Saúde Reproductive (there may be other sites in this country)
São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients

ClinicalTrials.gov · NCT03954197 · Registry updated: 2019-05-20

Condition / research focus: Fertility Preservation; Breast Cancer
Sponsor: Hôpital Jean Verdier
Countries with listed sites: France
Registry dates and results: Start: 2014-09-09. Completion: 2019-10-09 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

No hormone (other)
hCG (other)
GnRH a (other)

Where the study takes place — 1 listed sites

Hôpital Jean Verdier
Bondy, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)

ClinicalTrials.gov · NCT01154192 · Registry updated: 2019-04-30

Condition / research focus: PCOS
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2011-08. Completion: 2014-09 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dexamethasone (drug) — also listed as: recombinant human chorionic gonadotropin (r-hCG)
recombinant human chorionic gonadotropin (r-hCG) (drug) — also listed as: Ovidrel

Where the study takes place — 1 listed sites

UCSD School of Medicine
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Timing and Intrauterine Insemination in Unexplained Infertility

ClinicalTrials.gov · NCT03920514 · Registry updated: 2019-04-19

Condition / research focus: Intrauterine Insemination
Sponsor: Sohag University
Countries with listed sites: No country reported
Registry dates and results: Start: 2019-04-30. Completion: 2019-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug) — also listed as: Pregnyl

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Value of Myomectomy in Women With Intramural Myoma Before IVF.

ClinicalTrials.gov · NCT03904368 · Registry updated: 2019-04-05

Condition / research focus: Fibroid Uterus; IVF
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-04. Completion: 2020-12 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Open myomectomy (procedure)
Gonadotropins (drug) — also listed as: Controlled Ovarian stimulation
Human chorionic gonadotropin (drug) — also listed as: Ovulation triggering
Ovum pick up (procedure)
Embryo transfer (procedure)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Triggering of Follicular Maturation

ClinicalTrials.gov · NCT02916173 · Registry updated: 2019-03-20

Condition / research focus: Increase Pregnancy Rate
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-11. Completion: 2019-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Recombinant Human Chorionic Gonadotrophin (drug) — also listed as: Ovitrelle
human chorionic gonadotrophin + gonadotrophin releasing hormone agonist (drug)

Where the study takes place — 1 listed sites

Ahmed Abbas
Assiut, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Natural Cycle Versus Stimulated Cycle Before Frozen Embryo Transfer

ClinicalTrials.gov · NCT02834117 · Registry updated: 2019-02-06

Condition / research focus: Fertility
Sponsor: Dr Massin Nathalie
Countries with listed sites: France
Registry dates and results: Start: 2015-05. Completion: 2018-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

natural cycle (other) — also listed as: natural
moderate ovarian stimulation (drug) — also listed as: ovarian stimulation

Where the study takes place — 1 listed sites

CHI Creteil
Créteil, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination.

ClinicalTrials.gov · NCT03825445 · Registry updated: 2019-01-31

Condition / research focus: Ovulation Induction
Sponsor: Hue University of Medicine and Pharmacy
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-04-01. Completion: 2017-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRHa (Fertipeptil 0.1mg) (drug)
hCG (Pregnyl 5000IU) (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Timing of HCG Administration in IUI Cycles

ClinicalTrials.gov · NCT02330705 · Registry updated: 2019-01-25

Condition / research focus: Infertility
Sponsor: Mohamed Ibrahem Eid
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-01. Completion: 2019-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HCG (drug) — also listed as: Pregnyl

Where the study takes place — 2 listed sites

Fertility care unit (FCU) in Mansoura University Hospitals
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Recruiting
Private fertility care centers
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation

ClinicalTrials.gov · NCT03809221 · Registry updated: 2019-01-18

Condition / research focus: Infertility, Female
Sponsor: Peking University People's Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2019-02-01. Completion: 2020-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triptorelin acetate (drug) — also listed as: recombinant follicular stimulating hormone (rFSH), recombinant luteinizing hormone (rLH), urinanry human postmenopausal gonadotropin (HMG)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Frozen Embryo Transfer on Cycle Outcomes

ClinicalTrials.gov · NCT02355925 · Registry updated: 2018-12-28

Condition / research focus: Infertility
Sponsor: Royan Institute
Countries with listed sites: Iran
Registry dates and results: Start: 2014-10. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intrauterine injection of uhCG (drug)
Placebo (drug)
control (other)

Where the study takes place — 1 listed sites

Royan Institute
Tehran, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Embryo Transfer on Pregnancy Outcomes in Frozen Embryo Transfer Cycles.

ClinicalTrials.gov · NCT02825108 · Registry updated: 2018-12-28

Condition / research focus: Infertility
Sponsor: Royan Institute
Countries with listed sites: Iran
Registry dates and results: Start: 2015-01. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intra uterine injection of tissue culture medium containing HCG+ET (drug)
Intra uterine injection of tissue culture medium +ET (drug)
ET (procedure)

Where the study takes place — 1 listed sites

Royan Institute
Tehran, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI

ClinicalTrials.gov · NCT03784404 · Registry updated: 2018-12-21

Condition / research focus: Ovarian Endometrioma
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-12. Completion: 2019-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Transvaginal aspiration (procedure)
transvaginal aspiration and surgicel injection (procedure)
Intracytoplasmic sperm injection (drug)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF Success

ClinicalTrials.gov · NCT02606500 · Registry updated: 2018-11-26

Condition / research focus: Obesity
Sponsor: University Medical Centre Ljubljana
Countries with listed sites: Slovenia
Registry dates and results: Start: 2016-03. Completion: 2017-03 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Elonva (drug)

Where the study takes place — 1 listed sites

Division of gynecology, Department of human reproduction
Ljubljana, Slovenia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)

ClinicalTrials.gov · NCT00747617 · Registry updated: 2018-11-21

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2007-09. Completion: 2010-09 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

recombinant human chorionic gonadotropin (drug) — also listed as: Ovidrel

Where the study takes place — 1 listed sites

University of California, San Diego, School of Medicine
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

ClinicalTrials.gov · NCT01606709 · Registry updated: 2018-11-21

Condition / research focus: Endometrial Receptivity; Ovarian Hyperstimulation Syndrome
Sponsor: UConn Health
Countries with listed sites: United States
Registry dates and results: Start: 2012-04. Completion: 2014-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH agonist (drug) — also listed as: leuprolide acetate,, lupron
hCG (drug) — also listed as: Pregnyl

Where the study takes place — 1 listed sites

UCHC Division of Reproductive Endocrinology
Farmington, Connecticut, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients

ClinicalTrials.gov · NCT02273791 · Registry updated: 2018-10-29

Condition / research focus: Infertility; Polycystic Ovarian Syndrome
Sponsor: Mansoura University
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-12. Completion: 2016-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Estradiol valerate (drug) — also listed as: Cycloprogynova (white tablets)
Sequential Clomiphene citrate and Gonadotropin (drug) — also listed as: Sequential Clomid and Menogon

Where the study takes place — 2 listed sites

Fertility Care Unit (FCU) in Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported
Private fertility care centers
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

ClinicalTrials.gov · NCT01815138 · Registry updated: 2018-10-26

Condition / research focus: Ovarian Hyperstimulation Syndrome
Sponsor: UConn Health
Countries with listed sites: United States
Registry dates and results: Start: 2013-03. Completion: 2016-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug) — also listed as: Pregnyl, Profasi
hCG (drug) — also listed as: Pregnyl, Profasi

Where the study takes place — 1 listed sites

University of Connecticut Health Center
Farmington, Connecticut, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment

ClinicalTrials.gov · NCT01882166 · Registry updated: 2018-09-14

Condition / research focus: Infertility, Female
Sponsor: St. Olavs Hospital
Countries with listed sites: Norway
Registry dates and results: Start: 2013-10. Completion: 2015-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

fostimon (drug) — also listed as: urinary FSH
puregon (drug) — also listed as: recombinant FSH

Where the study takes place — 1 listed sites

IVF Unit, St. Olavs Hospital
Trondheim, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)

ClinicalTrials.gov · NCT02625519 · Registry updated: 2018-08-28

Condition / research focus: Reproductive Techniques, Assisted
Sponsor: Instituto Bernabeu
Countries with listed sites: Spain
Registry dates and results: Start: 2015-12. Completion: 2019-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Urinary follicle-stimulating hormone (drug) — also listed as: urinary FSH, Fostipur®
Recombinant follicle-stimulating hormone (drug) — also listed as: recombinant FSH, Bemfola®

Where the study takes place — 1 listed sites

Instituto Bernabeu
Alicante, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:16 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3CompletedINTERVENTIONAL

A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation

ClinicalTrials.gov · NCT02449889 · Registry updated: 2019-06-26

Condition / research focus: Infertility
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: Brazil
Registry dates and results: Start: 2016-04. Completion: 2018-03-01 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

highly purified human chorionic gonadotropin (drug) — also listed as: CHORAPUR, BREVACTID
recombinant human chorionic gonadotropin (drug) — also listed as: OVIDREL, OVITRELLE

Where the study takes place — 1 listed sites

Instituto Ideia Fértil de Saúde Reproductive (there may be other sites in this country)
São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients

ClinicalTrials.gov · NCT03954197 · Registry updated: 2019-05-20

Condition / research focus: Fertility Preservation; Breast Cancer
Sponsor: Hôpital Jean Verdier
Countries with listed sites: France
Registry dates and results: Start: 2014-09-09. Completion: 2019-10-09 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

No hormone (other)
hCG (other)
GnRH a (other)

Where the study takes place — 1 listed sites

Hôpital Jean Verdier
Bondy, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)

ClinicalTrials.gov · NCT01154192 · Registry updated: 2019-04-30

Condition / research focus: PCOS
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2011-08. Completion: 2014-09 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dexamethasone (drug) — also listed as: recombinant human chorionic gonadotropin (r-hCG)
recombinant human chorionic gonadotropin (r-hCG) (drug) — also listed as: Ovidrel

Where the study takes place — 1 listed sites

UCSD School of Medicine
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Timing and Intrauterine Insemination in Unexplained Infertility

ClinicalTrials.gov · NCT03920514 · Registry updated: 2019-04-19

Condition / research focus: Intrauterine Insemination
Sponsor: Sohag University
Countries with listed sites: No country reported
Registry dates and results: Start: 2019-04-30. Completion: 2019-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug) — also listed as: Pregnyl

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Value of Myomectomy in Women With Intramural Myoma Before IVF.

ClinicalTrials.gov · NCT03904368 · Registry updated: 2019-04-05

Condition / research focus: Fibroid Uterus; IVF
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-04. Completion: 2020-12 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Open myomectomy (procedure)
Gonadotropins (drug) — also listed as: Controlled Ovarian stimulation
Human chorionic gonadotropin (drug) — also listed as: Ovulation triggering
Ovum pick up (procedure)
Embryo transfer (procedure)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Triggering of Follicular Maturation

ClinicalTrials.gov · NCT02916173 · Registry updated: 2019-03-20

Condition / research focus: Increase Pregnancy Rate
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-11. Completion: 2019-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Recombinant Human Chorionic Gonadotrophin (drug) — also listed as: Ovitrelle
human chorionic gonadotrophin + gonadotrophin releasing hormone agonist (drug)

Where the study takes place — 1 listed sites

Ahmed Abbas
Assiut, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Natural Cycle Versus Stimulated Cycle Before Frozen Embryo Transfer

ClinicalTrials.gov · NCT02834117 · Registry updated: 2019-02-06

Condition / research focus: Fertility
Sponsor: Dr Massin Nathalie
Countries with listed sites: France
Registry dates and results: Start: 2015-05. Completion: 2018-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

natural cycle (other) — also listed as: natural
moderate ovarian stimulation (drug) — also listed as: ovarian stimulation

Where the study takes place — 1 listed sites

CHI Creteil
Créteil, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination.

ClinicalTrials.gov · NCT03825445 · Registry updated: 2019-01-31

Condition / research focus: Ovulation Induction
Sponsor: Hue University of Medicine and Pharmacy
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-04-01. Completion: 2017-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRHa (Fertipeptil 0.1mg) (drug)
hCG (Pregnyl 5000IU) (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Timing of HCG Administration in IUI Cycles

ClinicalTrials.gov · NCT02330705 · Registry updated: 2019-01-25

Condition / research focus: Infertility
Sponsor: Mohamed Ibrahem Eid
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-01. Completion: 2019-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HCG (drug) — also listed as: Pregnyl

Where the study takes place — 2 listed sites

Fertility care unit (FCU) in Mansoura University Hospitals
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Recruiting
Private fertility care centers
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation

ClinicalTrials.gov · NCT03809221 · Registry updated: 2019-01-18

Condition / research focus: Infertility, Female
Sponsor: Peking University People's Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2019-02-01. Completion: 2020-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triptorelin acetate (drug) — also listed as: recombinant follicular stimulating hormone (rFSH), recombinant luteinizing hormone (rLH), urinanry human postmenopausal gonadotropin (HMG)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Frozen Embryo Transfer on Cycle Outcomes

ClinicalTrials.gov · NCT02355925 · Registry updated: 2018-12-28

Condition / research focus: Infertility
Sponsor: Royan Institute
Countries with listed sites: Iran
Registry dates and results: Start: 2014-10. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intrauterine injection of uhCG (drug)
Placebo (drug)
control (other)

Where the study takes place — 1 listed sites

Royan Institute
Tehran, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Embryo Transfer on Pregnancy Outcomes in Frozen Embryo Transfer Cycles.

ClinicalTrials.gov · NCT02825108 · Registry updated: 2018-12-28

Condition / research focus: Infertility
Sponsor: Royan Institute
Countries with listed sites: Iran
Registry dates and results: Start: 2015-01. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intra uterine injection of tissue culture medium containing HCG+ET (drug)
Intra uterine injection of tissue culture medium +ET (drug)
ET (procedure)

Where the study takes place — 1 listed sites

Royan Institute
Tehran, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI

ClinicalTrials.gov · NCT03784404 · Registry updated: 2018-12-21

Condition / research focus: Ovarian Endometrioma
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-12. Completion: 2019-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Transvaginal aspiration (procedure)
transvaginal aspiration and surgicel injection (procedure)
Intracytoplasmic sperm injection (drug)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF Success

ClinicalTrials.gov · NCT02606500 · Registry updated: 2018-11-26

Condition / research focus: Obesity
Sponsor: University Medical Centre Ljubljana
Countries with listed sites: Slovenia
Registry dates and results: Start: 2016-03. Completion: 2017-03 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Elonva (drug)

Where the study takes place — 1 listed sites

Division of gynecology, Department of human reproduction
Ljubljana, Slovenia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)

ClinicalTrials.gov · NCT00747617 · Registry updated: 2018-11-21

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2007-09. Completion: 2010-09 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

recombinant human chorionic gonadotropin (drug) — also listed as: Ovidrel

Where the study takes place — 1 listed sites

University of California, San Diego, School of Medicine
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

ClinicalTrials.gov · NCT01606709 · Registry updated: 2018-11-21

Condition / research focus: Endometrial Receptivity; Ovarian Hyperstimulation Syndrome
Sponsor: UConn Health
Countries with listed sites: United States
Registry dates and results: Start: 2012-04. Completion: 2014-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH agonist (drug) — also listed as: leuprolide acetate,, lupron
hCG (drug) — also listed as: Pregnyl

Where the study takes place — 1 listed sites

UCHC Division of Reproductive Endocrinology
Farmington, Connecticut, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients

ClinicalTrials.gov · NCT02273791 · Registry updated: 2018-10-29

Condition / research focus: Infertility; Polycystic Ovarian Syndrome
Sponsor: Mansoura University
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-12. Completion: 2016-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Estradiol valerate (drug) — also listed as: Cycloprogynova (white tablets)
Sequential Clomiphene citrate and Gonadotropin (drug) — also listed as: Sequential Clomid and Menogon

Where the study takes place — 2 listed sites

Fertility Care Unit (FCU) in Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported
Private fertility care centers
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

ClinicalTrials.gov · NCT01815138 · Registry updated: 2018-10-26

Condition / research focus: Ovarian Hyperstimulation Syndrome
Sponsor: UConn Health
Countries with listed sites: United States
Registry dates and results: Start: 2013-03. Completion: 2016-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug) — also listed as: Pregnyl, Profasi
hCG (drug) — also listed as: Pregnyl, Profasi

Where the study takes place — 1 listed sites

University of Connecticut Health Center
Farmington, Connecticut, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment

ClinicalTrials.gov · NCT01882166 · Registry updated: 2018-09-14

Condition / research focus: Infertility, Female
Sponsor: St. Olavs Hospital
Countries with listed sites: Norway
Registry dates and results: Start: 2013-10. Completion: 2015-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

fostimon (drug) — also listed as: urinary FSH
puregon (drug) — also listed as: recombinant FSH

Where the study takes place — 1 listed sites

IVF Unit, St. Olavs Hospital
Trondheim, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)

ClinicalTrials.gov · NCT02625519 · Registry updated: 2018-08-28

Condition / research focus: Reproductive Techniques, Assisted
Sponsor: Instituto Bernabeu
Countries with listed sites: Spain
Registry dates and results: Start: 2015-12. Completion: 2019-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Urinary follicle-stimulating hormone (drug) — also listed as: urinary FSH, Fostipur®
Recombinant follicle-stimulating hormone (drug) — also listed as: recombinant FSH, Bemfola®

Where the study takes place — 1 listed sites

Instituto Bernabeu
Alicante, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →